---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-22-000312"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2022-03-23T23:59:59+00:00"
generated_at: "2026-06-26T19:27:16.667791+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# IGC appoints Claudia Grimaldi to Board as non-independent director

## Summary
- Claudia Grimaldi appointed to the Board as non-independent director, effective March 23, 2022.
- Board now has 5 directors, majority independent; Grimaldi currently VP, Principal Finance Officer, and CCO.
- Grimaldi's employment agreement provides $150K base salary, benefits, and 18-month severance on termination without cause.
- She also serves as Managing Director of Hamsa Biochem SAS (Colombia subsidiary) and director of India subsidiary.

## SEC filing metadata
- accession: 0001185185-22-000312
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2022-03-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518522000312/0001185185-22-000312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518522000312/indiaglob20220323_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-22-000312
- JSON: https://secwatch.observer/filing/0001185185-22-000312.json
- Plain text: https://secwatch.observer/filing/0001185185-22-000312.txt

## Key facts
- Executive change
  Claudia Grimaldi was appointed as Director at IGC Pharma, Inc..
  - Action: appointed
  - Role: Director
  source text: On March 23, 2022, the Board of Directors (the “Board”) of India Globalization Capital Inc. (the “Company” “IGC” or “we”) appointed Ms. Claudia Grimaldi (“Ms. Grimaldi”) to serve on the Board as a non-independent director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518522000312/0001185185-22-000312-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.